{"id":"fibrinogen-concentrate-human","safety":{"commonSideEffects":[{"rate":null,"effect":"Thromboembolism"},{"rate":null,"effect":"Allergic/hypersensitivity reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Chills"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fibrinogen (Factor I) is a critical plasma protein essential for the final step of the coagulation cascade, where it is converted to fibrin to form stable blood clots. This concentrate provides exogenous fibrinogen to patients with congenital or acquired fibrinogen deficiency, enabling restoration of hemostatic capacity and reduction of bleeding risk.","oneSentence":"Fibrinogen Concentrate Human replaces or supplements deficient fibrinogen to restore normal blood clotting function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:39:47.369Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Congenital fibrinogen deficiency (afibrinogenemia or hypofibrinogenemia)"},{"name":"Acquired fibrinogen deficiency"},{"name":"Perioperative bleeding management in fibrinogen-deficient patients"}]},"trialDetails":[{"nctId":"NCT06617897","phase":"PHASE3","title":"Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery","status":"RECRUITING","sponsor":"CSL Behring","startDate":"2024-10-01","conditions":"Acquired Fibrinogen Deficiency","enrollment":90},{"nctId":"NCT04376762","phase":"PHASE4","title":"Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2021-10-26","conditions":"Pediatric HD, Bleeding","enrollment":31},{"nctId":"NCT05091684","phase":"PHASE2","title":"Administration of Fibrinogen Concentrate for Refractory Bleeding","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2022-02-10","conditions":"Hematological Patients, Bleeding, Platelet Refractoriness","enrollment":1},{"nctId":"NCT02065882","phase":"PHASE3","title":"Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency","status":"COMPLETED","sponsor":"Biotest","startDate":"2013-03","conditions":"Congenital Afibrinogenemia, Congenital Hypofibrinogenemia","enrollment":67},{"nctId":"NCT03793426","phase":"","title":"Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency","status":"TERMINATED","sponsor":"Octapharma","startDate":"2021-01-28","conditions":"Congenital Fibrinogen Deficiency","enrollment":7},{"nctId":"NCT03444324","phase":"PHASE3","title":"Adjusted Fibrinogen Replacement Strategy","status":"COMPLETED","sponsor":"Biotest","startDate":"2018-04-03","conditions":"Bleeding Disorder, Hypofibrinogenemia; Acquired","enrollment":222},{"nctId":"NCT04602689","phase":"NA","title":"Fibrin Glue After ESD for High Risk Patients of Bleeding","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2020-10-30","conditions":"Early Gastric Cancer, Gastric Adenoma","enrollment":134},{"nctId":"NCT05780125","phase":"PHASE2","title":"Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness","status":"COMPLETED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2023-03-20","conditions":"Hypofibrinogenemia, Surgical Blood Loss, Bleeding","enrollment":40},{"nctId":"NCT03780894","phase":"PHASE1, PHASE2","title":"Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.","status":"COMPLETED","sponsor":"Banc de Sang i Teixits","startDate":"2018-11-21","conditions":"Polytrauma, Traumatic Hemorrhage","enrollment":79},{"nctId":"NCT04636268","phase":"PHASE3","title":"FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis","status":"WITHDRAWN","sponsor":"Instituto Grifols, S.A.","startDate":"2023-12","conditions":"Congenital Afibrinogenemia, Hypofibrinogenemia","enrollment":""},{"nctId":"NCT03461406","phase":"PHASE3","title":"A Study of Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Participants","status":"COMPLETED","sponsor":"Instituto Grifols, S.A.","startDate":"2019-01-18","conditions":"Excessive Bleeding During Surgery","enrollment":186},{"nctId":"NCT05391412","phase":"PHASE4","title":"Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery","status":"UNKNOWN","sponsor":"Brno University Hospital","startDate":"2022-06-06","conditions":"Fibrinogen, Spine Deformity, Coagulopathy, Consumption","enrollment":32},{"nctId":"NCT00916656","phase":"PHASE3","title":"Fibrinogen Concentrate (Human) - Efficacy and Safety Study","status":"WITHDRAWN","sponsor":"CSL Behring","startDate":"2009-10","conditions":"Afibrinogenemia, Hypofibrinogenemia, Fibrinogen Deficiency","enrollment":""},{"nctId":"NCT02557672","phase":"PHASE4","title":"PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-08","conditions":"Bleeding, Blood Loss, Surgical, Cardiovascular Surgical Procedures","enrollment":106},{"nctId":"NCT02281500","phase":"PHASE1, PHASE2","title":"Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia","status":"COMPLETED","sponsor":"Grifols Therapeutics LLC","startDate":"2016-07-22","conditions":"Congenital Afibrinogenemia","enrollment":24},{"nctId":"NCT04405518","phase":"PHASE4","title":"Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.","status":"UNKNOWN","sponsor":"Antoni Sabaté Pes","startDate":"2019-06-17","conditions":"Fibrin Blood Clot","enrollment":188},{"nctId":"NCT04434001","phase":"PHASE2","title":"ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery","status":"TERMINATED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2020-02-27","conditions":"Bleeding, Cardiac Defect, Surgery--Complications","enrollment":40},{"nctId":"NCT02822599","phase":"PHASE4","title":"Human Fibrinogen Concentrate in Pediatric Cardiac Surgery","status":"COMPLETED","sponsor":"Nicklaus Children's Hospital f/k/a Miami Children's Hospital","startDate":"2017-06-01","conditions":"Hypofibrinogenemia, Afibrinogenemia, Bleeding Disorders","enrollment":30},{"nctId":"NCT03784794","phase":"NA","title":"Patient Blood Management for Massive Obstetric Hemorrhage","status":"COMPLETED","sponsor":"Angel Augusto Perez Calatayud","startDate":"2018-11-01","conditions":"Post Partum Hemorrhage, Fibrinogenolysis; Hemorrhage, Fibrinogen; Deficiency, Acquired","enrollment":100},{"nctId":"NCT02155725","phase":"PHASE4","title":"Fibrinogen in Haemorrhage of Delivery","status":"COMPLETED","sponsor":"Laboratoire français de Fractionnement et de Biotechnologies","startDate":"2014-04-10","conditions":"Post-Partum Hemorrhage","enrollment":448},{"nctId":"NCT03183479","phase":"PHASE4","title":"The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2017-06-14","conditions":"Scoliosis; Adolescence, Bleeding, Surgery","enrollment":102},{"nctId":"NCT03304899","phase":"PHASE1, PHASE2","title":"Fibrinogen Concentrate in Isolated Traumatic Brain Injury","status":"UNKNOWN","sponsor":"Leila Dehghani","startDate":"2018-10-23","conditions":"Traumatic Brain Injury, Hemorrhage","enrollment":50},{"nctId":"NCT01283321","phase":"PHASE2","title":"RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery","status":"TERMINATED","sponsor":"Emory University","startDate":"2011-01","conditions":"Heart Valve Disease, Coronary Artery Disease","enrollment":26},{"nctId":"NCT02427217","phase":"","title":"An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2015-05-07","conditions":"Congenital Fibrinogen Deficiency","enrollment":22},{"nctId":"NCT00512356","phase":"PHASE2","title":"Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2000-12","conditions":"Intraperitoneal Adhesions","enrollment":46},{"nctId":"NCT02344069","phase":"PHASE2","title":"Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2015-02","conditions":"Trauma, Haemorrhage","enrollment":40},{"nctId":"NCT00496262","phase":"PHASE2","title":"Human Fibrinogen - Pharmacokinetics","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2007-07","conditions":"Fibrinogen Deficiency","enrollment":15},{"nctId":"NCT02203968","phase":"PHASE1, PHASE2","title":"Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2014-10","conditions":"Trauma, Injury, Bleeding","enrollment":50},{"nctId":"NCT01955811","phase":"PHASE4","title":"Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion","status":"COMPLETED","sponsor":"Medical University Innsbruck","startDate":"2012-12","conditions":"Blood Platelet Transfusion, Blood Clotting","enrollment":130},{"nctId":"NCT02094430","phase":"PHASE2, PHASE3","title":"Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency","status":"COMPLETED","sponsor":"Laboratoire français de Fractionnement et de Biotechnologies","startDate":"2014-01","conditions":"Hypofibrinogenemia, Congenital, Afibrinogenemia, Congenital","enrollment":16},{"nctId":"NCT01475344","phase":"PHASE1, PHASE2","title":"Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)","status":"COMPLETED","sponsor":"Medical University Innsbruck","startDate":"2011-09","conditions":"Trauma, Massive Hemorrhage","enrollment":67},{"nctId":"NCT01471730","phase":"PHASE3","title":"The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery","status":"COMPLETED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2011-11","conditions":"Heart Disease","enrollment":119},{"nctId":"NCT01124981","phase":"PHASE2, PHASE3","title":"Haemocomplettan® P During Elective Complex Cardiac Surgery","status":"COMPLETED","sponsor":"Isala","startDate":"2011-02","conditions":"Fibrinogen Deficiency in Complex Cardiac Surgery","enrollment":120},{"nctId":"NCT01487837","phase":"PHASE4","title":"Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.","status":"COMPLETED","sponsor":"University Children's Hospital, Zurich","startDate":"2012-01","conditions":"Blood Coagulation Disorders, Hemorrhage","enrollment":57},{"nctId":"NCT01475669","phase":"PHASE3","title":"Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2012-01","conditions":"Surgical Blood Loss, Postoperative Blood Loss","enrollment":152}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2574,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Haemocomplettan","FIBRORAAS","HAEMOCOMPLETTAN P","Chlotafact"],"phase":"marketed","status":"active","brandName":"Fibrinogen Concentrate Human","genericName":"Fibrinogen Concentrate Human","companyName":"IRCCS Policlinico S. Donato","companyId":"irccs-policlinico-s-donato","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fibrinogen Concentrate Human replaces or supplements deficient fibrinogen to restore normal blood clotting function. Used for Congenital fibrinogen deficiency (afibrinogenemia or hypofibrinogenemia), Acquired fibrinogen deficiency, Perioperative bleeding management in fibrinogen-deficient patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":4,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}